Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
BMC Surg20 Nov 2023

Shrinking Tumors, Elevating Hope: FOLFIRINOX Impact on Pancreatic Cancer Resectability and Survival

In pancreatic cancer patients receiving FOLFIRINOX, tumor size reduction significantly increased resectability and pathologic response. Normalization of carbohydrate antigen 19-9 levels predicted resectability, lower recurrence risk, and improved survival. Postoperative antigen 19-9 rise, following prior normalization after neoadjuvant therapy, signaled heightened recurrence risk and poorer…

Langenbecks Arch Surg20 Nov 2023

Sarcopenia Signals Poor Outcomes in Recurrent Hepatocellular Carcinoma

Patients with early-stage recurrent hepatocellular carcinoma and sarcopenia face significantly lower overall and recurrence-free survival rates, regardless of treatment type. Sarcopenia emerges as an independent prognostic factor, suggesting a crucial role in long-term outcomes. Notably, impaired host immunity, evidenced by low levels of tumor-infiltrating lymphocytes,…

Langenbecks Arch Surg20 Nov 2023

Optimizing Laparoscopic Pancreaticoduodenectomy: ‘1+2’ Stitch Shows Superiority in Pancreaticojejunostomy

In a game-changing move, researchers explored the "1+2" technique for pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Among 184 cases, this approach exhibited success in all 95 "1+2" cases, showcasing advantages over the traditional method. The new technique boasted shorter operation and pancreaticojejunostomy times, reduced complications, lower infection…

Langenbecks Arch Surg20 Nov 2023

Appendicitis Complexity Impacts Cancer Type

Analyzing 4 studies with 4,962 appendicitis patients, the meta-analysis found a 1.98% neoplasm incidence. No overall difference emerged between complicated (3.29%) and uncomplicated (1.49%) cases. Neuroendocrine tumors (NET) were common (49.21%), with higher rates in uncomplicated cases, while adenocarcinomas were more prevalent in complicated appendicitis…

Am J Surg Pathol19 Nov 2023

DNA Methylation Classifier Illuminates Sarcoma Diagnoses and Molecular Markers

Researchers evaluated a sarcoma DNA methylation classifier for soft tissue and bone tumors, including 619 cases. The classifier exhibited high sensitivity and specificity for fusion sarcomas (Ewing, synovial, cic-rearranged, bcor-rearranged), leiomyosarcoma, MPNST, and malignant vascular tumors. However, sensitivity was low for desmoid fibromatosis, neurofibroma, and…

Ann Surg Oncol19 Nov 2023

Laparoscopic Limited Anatomic Liver Resections: Precise Technique Yields Promising Oncologic Outcomes

Exploring laparoscopic liver surgeries, researchers scrutinized 112 patients undergoing laparoscopically limited anatomic resections (LARs) for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). Impressively, lap-LAR demonstrated precise technique, yielding promising oncologic outcomes with low complications. Five-year recurrence-free survival rates for HCC and CRLM stood at…

Ann Surg Oncol19 Nov 2023

Surgery Shines: A Viable Treatment Avenue for Stage IE Primary Thyroid Lymphoma

Surgery emerges as a viable treatment for stage IE primary thyroid lymphoma (PTL), with a cohort study of 1,596 patients (SEER database) and an external cohort of 38 patients (Shanghai, China). The 7.8-year SEER analysis showed no significant survival difference between surgery, surgery + radiotherapy/chemotherapy,…